Inhibition of reovirus by mycophenolic acid is associated with the M1 genome segment.
Mycophenolic acid (MPA), an inhibitor of IMP dehydrogenase, inhibits reovirus replication and viral RNA and protein production. In mouse L929 cells, antiviral effects were greatest at 30 microg of MPA/ml. At this dosage, MPA inhibited replication of reovirus strain T3D more than 1,000-fold and inhibited replication of reovirus strain T1L nearly 100-fold, compared to non-drug-treated controls. Genetic reassortant analysis indicated the primary determinant of strain-specific differences in sensitivity to MPA mapped to the viral M1 genome segment, which encodes the minor core protein mu2. MPA also inhibited replication of both strains of reovirus in a variety of other cell lines, including Vero monkey kidney and U373 human astrocytoma cells. Addition of exogenous guanosine to MPA-treated reovirus-infected cells restored viral replicative capacity to nearly normal levels. These results suggest the mu2 protein is involved in the uptake and processing of GTP in viral transcription in infected cells and strengthens the evidence that the mu2 protein can function as an NTPase and is likely a transcriptase cofactor.
Hermann
Laura L
LL
Department of Medical Microbiology and Infectious Diseases, University of Manitoba, 730 William Avenue, Winnipeg, Manitoba, Canada R3E 0W3.
Coombs
Kevin M
KM
D000818:Animals; D002522:Chlorocebus aethiops; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D016679:Genome, Viral; D006801:Humans; D007739:L Cells; D051379:Mice; D009173:Mycophenolic Acid / Q000494:pharmacology*; D018165:Orthoreovirus / Q000145:classification / Q000187:drug effects* / Q000235:genetics; D012367:RNA, Viral / Q000096:biosynthesis / Q000187:drug effects; D014709:Vero Cells; D014764:Viral Proteins / Q000187:drug effects / Q000235:genetics; D014779:Virus Replication / Q000187:drug effects*
D004791:Enzyme Inhibitors; D012367:RNA, Viral; D014764:Viral Proteins; C410663:mu2 protein, Reovirus; D009173:Mycophenolic Acid